Surgical Robot Performs Fully Autonomous Kidney Transplant in Pre-Clinical Trial

A next-generation surgical robot developed by a Johns Hopkins-led consortium has completed a fully autonomous kidney transplant in a pre-clinical porcine model with no human intervention. The procedure, which anastomosed the renal artery, vein, and ureter, took 47 minutes and produced a viable graft. The team says it will file for FDA Investigational Device Exemption to begin human trials in 2027.

What the Robot Did

The system uses a combination of preoperative imaging, intraoperative computer vision, and a reinforcement-learning-trained motion planner. Unlike teleoperated systems such as the da Vinci, no human operator issued motion commands. The robot performed dissection, vessel preparation, anastomosis, and verification end-to-end. Two attending surgeons observed but did not intervene.

"This is not autonomous surgery as a demo. This is autonomous surgery as a research result, with rigorous metrics and full clinical-grade instrumentation," said Dr. Axel Krieger, who leads the program.

Why It Matters

The transplant is one of the most technically demanding soft-tissue procedures in surgery. The vascular anastomoses are unforgiving: a single misplaced stitch can lose the graft. The fact that a robot executed them with sub-millimeter precision — and reproduced the result across multiple animal cases — is a watershed moment for autonomy in surgery.

• Procedure time: 47 minutes (porcine transplant)
• Success rate across 12 cases: 11/12 viable grafts
• Anastomosis precision: Sub-millimeter
• Planned first-in-human: 2027

What's Next

The team's near-term focus is on simpler, higher-volume procedures: cholecystectomy, hysterectomy, and prostatectomy. These would establish the safety and reproducibility of autonomous robotic surgery across thousands of cases before tackling the most complex operations. The consortium includes Intuitive Surgical, whose da Vinci platform dominates the field today.

The broader question for medicine is not whether autonomous surgery will arrive, but how regulators, surgeons, and patients will accept it. The technology is moving faster than the legal and ethical frameworks for autonomous clinical action. The first human case will be the most-watched operation of the decade.